Literature DB >> 11515855

The Nod2 gene in Crohn's disease: implications for future research into the genetics and immunology of Crohn's disease.

J H Cho1.   

Abstract

The association of the Nod2 gene on chromosome 16 with increased susceptibility to Crohn's disease holds the promise of catalyzing fundamental genetic and therapeutic advances. Coding region variants in the leucine-rich repeat region of Nod2 may affect host interactions with bacterial lipopolysaccharide. Genetic differences in pattern-recognition proteins (such as Nod2) of the innate immune system represent an increasingly important paradigm for understanding host-environment interactions. The central problem for complex disease gene identification through genome-wide searches has been that of locus heterogeneity; it is hoped that this heterogeneity will recede with the identification of Nod2, as the first pieces of a puzzle accelerate placement of subsequent pieces. The potential for genetic approaches to positively impact the treatment of Crohn's disease and ulcerative colitis is unparalleled among complex, multigenic disorders.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11515855     DOI: 10.1097/00054725-200108000-00014

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  10 in total

1.  Appendix redux.

Authors:  D B Sachar
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

Review 2.  Immunopathogenesis of IBD: insufficient suppressor function in the gut?

Authors:  I L Huibregtse; A U van Lent; S J H van Deventer
Journal:  Gut       Date:  2006-10-17       Impact factor: 23.059

Review 3.  Genome-virome interactions: examining the role of common viral infections in complex disease.

Authors:  Ellen F Foxman; Akiko Iwasaki
Journal:  Nat Rev Microbiol       Date:  2011-04       Impact factor: 60.633

4.  Contribution of genetics to a new vision in the understanding of inflammatory bowel disease.

Authors:  A S Peña
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

5.  Mouse paneth cell secretory responses to cell surface glycolipids of virulent and attenuated pathogenic bacteria.

Authors:  Hiroki Tanabe; Tokiyoshi Ayabe; Brian Bainbridge; Tina Guina; Robert K Ernst; Richard P Darveau; Samuel I Miller; Andre J Ouellette
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

6.  Mucosal Inflammatory and Wound Healing Gene Programs Reveal Targets for Stricturing Behavior in Pediatric Crohn's Disease.

Authors:  Yael Haberman; Phillip Minar; Rebekah Karns; Phillip J Dexheimer; Sudhir Ghandikota; Samuel Tegge; Daniel Shapiro; Brianne Shuler; Suresh Venkateswaran; Tzipi Braun; Allison Ta; Thomas D Walters; Robert N Baldassano; Joshua D Noe; Joel Rosh; James Markowitz; Jennifer L Dotson; David R Mack; Richard Kellermayer; Anne M Griffiths; Melvin B Heyman; Susan S Baker; Dedrick Moulton; Ashish S Patel; Ajay S Gulati; Steven J Steiner; Neal LeLeiko; Anthony Otley; Maria Oliva-Hemker; David Ziring; Ranjana Gokhale; Sandra Kim; Stephen L Guthery; Stanley A Cohen; Scott Snapper; Bruce J Aronow; Michael Stephens; Greg Gibson; Jonathan R Dillman; Marla Dubinsky; Jeffrey S Hyams; Subra Kugathasan; Anil G Jegga; Lee A Denson
Journal:  J Crohns Colitis       Date:  2020-08-08       Impact factor: 9.071

Review 7.  Matrix metalloproteinases in inflammatory bowel disease: an update.

Authors:  Shane O'Sullivan; John F Gilmer; Carlos Medina
Journal:  Mediators Inflamm       Date:  2015-04-08       Impact factor: 4.711

Review 8.  Ocular complications of inflammatory bowel disease.

Authors:  Rana Mady; Will Grover; Salim Butrus
Journal:  ScientificWorldJournal       Date:  2015-03-23

Review 9.  Innate Lymphoid Cells in Crohn's Disease.

Authors:  Ying Wu; Jun Shen
Journal:  Front Immunol       Date:  2020-11-16       Impact factor: 7.561

10.  Ex vivo response to mucosal bacteria and muramyl dipeptide in inflammatory bowel disease.

Authors:  Claudia Loganes; Erica Valencic; Alessia Pin; Elisa Marini; Stefano Martelossi; Samuele Naviglio; Luigina De Leo; Tarcisio Not; Lorenzo Monasta; Alberto Tommasini; Annalisa Marcuzzi
Journal:  World J Gastroenterol       Date:  2016-11-28       Impact factor: 5.742

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.